Cardiometabolic Risk Factors Associated With Multidrug-Resistant Tuberculosis

CompletedOBSERVATIONAL
Enrollment

183

Participants

Timeline

Start Date

September 4, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

January 30, 2025

Conditions
Tuberculosis (TB)
Trial Locations (1)

33100

Mustang Hospital, Jomsom

All Listed Sponsors
lead

B.P. Koirala Institute of Health Sciences

OTHER

NCT07003581 - Cardiometabolic Risk Factors Associated With Multidrug-Resistant Tuberculosis | Biotech Hunter | Biotech Hunter